6. Dose Adjustments Based on Pharmacogenetics of CYP450 Enzymes

由 van Schaik, Ron H.N.
發表在 EJIFCC (2008)

The CYP3A4*22 allele affects the predictive value of a pharmacogenetic algorithm predicting tacrolimus predose concentrations

由 Elens, Laure, Hesselink, Dennis A, van Schaik, Ron H N, van Gelder, Teun
出版 2013

A Guide to the Current Web-Based Resources in Pharmacogenomics

由 Glubb, Dylan M., Paugh, Steven W., van Schaik, Ron H.N., Innocenti, Federico
出版 2013

Pharmacogenetics in Psychiatry: An Update on Clinical Usability

由 van Schaik, Ron H. N., Müller, Daniel J., Serretti, Alessandro, Ingelman-Sundberg, Magnus
發表在 Front Pharmacol (2020)

Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

由 Ravegnini, Gloria, Del Re, Marzia, Grolla, Ambra A., van Schaik, Ron H. N., Angelini, Sabrina
發表在 Front Pharmacol (2020)

Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks

由 Elens, Laure, Bouamar, Rachida, Shuker, Nauras, Hesselink, Dennis A, van Gelder, Teun, van Schaik, Ron H N
出版 2014

Effect of Short-Term Fasting on Systemic Cytochrome P450-Mediated Drug Metabolism in Healthy Subjects: A Randomized, Controlled, Crossover Study Using a Cocktail Approach

由 Lammers, Laureen A., Achterbergh, Roos, van Schaik, Ron H. N., Romijn, Johannes A., Mathôt, Ron A. A.
發表在 Clin Pharmacokinet (2017)

Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of CYP2D6, CYP2B6, and CYP3A4 genotype

由 Haage, Pernilla, Kronstrand, Robert, Josefsson, Martin, Calistri, Simona, van Schaik, Ron H. N., Green, Henrik, Kugelberg, Fredrik C.
發表在 Pharmacol Res Perspect (2018)

Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics

由 de Man, Femke M., Goey, Andrew K. L., van Schaik, Ron H. N., Mathijssen, Ron H. J., Bins, Sander
發表在 Clin Pharmacokinet (2018)

Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study

由 Becker, Matthijs L., Visser, Loes E., van Schaik, Ron H.N., Hofman, Albert, Uitterlinden, André G., Stricker, Bruno H.Ch.
出版 2009

OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users

由 Becker, Matthijs L., Visser, Loes E., van Schaik, Ron H. N., Hofman, Albert, Uitterlinden, André G., Stricker, Bruno H. Ch.
出版 2010

Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy

由 Mulder, Tessa A. M., de With, Mirjam, del Re, Marzia, Danesi, Romano, Mathijssen, Ron H. J., van Schaik, Ron H. N.
發表在 Cancers (Basel) (2021)

Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil

由 Gensburger, Olivier, Van Schaik, Ron H. N., Picard, Nicolas, Le Meur, Yannick, Rousseau, Annick, Woillard, Jean-Baptiste, Van Gelder, Teun, Marquet, Pierre
出版 2010

Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose

由 Berger, Florine A., Mulder, Midas B., ten Bosch‐Dijksman, Willemijn, van Schaik, Ron H.N., Coenen, Sandra, de Winter, Brenda C.M.
發表在 Br J Clin Pharmacol (2019)

Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants

由 Bijl, Monique J, Visser, Loes E, Hofman, Albert, Vulto, Arnold G, van Gelder, Teun, Stricker, Bruno H Ch, van Schaik, Ron H N
出版 2008

CYP3A5, ABCB1 and SLCO1B1 Polymorphisms and Pharmacokinetics and Virologic Outcome of Lopinavir/Ritonavir in HIV-infected Children

由 Rakhmanina, Natella Y., Neely, Michael, Van Schaik, Ron H.N., Gordish-Dressman, Heather, Williams, Keetra D., Soldin, Steven J., van den Anker, John N.
出版 2011

No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness

由 Koopmans, Anne B., Vinkers, David J., Poulina, Igmar T., Gelan, Petra J. A., van Schaik, Ron H. N., Hoek, Hans W., van Harten, Peter N.
發表在 Front Psychiatry (2018)

Variation in the CYP2D6 gene is associated with a lower serum sodium concentration in patients on antidepressants

由 Kwadijk-de Gijsel, Sonja, Bijl, Monique J, Visser, Loes E, van Schaik, Ron H N, Hofman, Albert, Vulto, Arnold G, van Gelder, Teun, Ch Stricker, Bruno H
出版 2009

Global pharmacogenomics within precision medicine: challenges and opportunities

由 Chenoweth, Meghan J., Giacomini, Kathleen M., Pirmohamed, Munir, Hill, Susan L., van Schaik, Ron H.N., Schwab, Matthias, Shuldiner, Alan R., Relling, Mary V., Tyndale, Rachel F.
發表在 Clin Pharmacol Ther (2019)

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

由 Oosten, Astrid W., Abrantes, João A., Jönsson, Siv, Matic, Maja, van Schaik, Ron H. N., de Bruijn, Peter, van der Rijt, Carin C. D., Mathijssen, Ron H. J.
發表在 Clin Pharmacokinet (2016)